Previous 10 | Next 10 |
Corporate presentation and live webcast scheduled for April 22, 2020 at 10:00am ET TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) tech...
Applied DNA Sciences (NASDAQ: APDN ) +61% on advancement of COVID-19 vaccine candidates. More news on: Applied DNA Sciences, Inc., Comstock Holding Companies, Inc., BOQI International Medical Inc., Stocks on the move, , Read more ...
TFF Pharmaceuticals (NASDAQ: TFFP ) has entered into a Cooperative Research and Development Agreement (CRADA) with the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID). More news on: TFF Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move, Read mor...
USAMRIID to study use of TFF technology to formulate dry powder neutralizing antibodies and vaccines against national priority biodefense threats for pulmonary delivery TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commer...
Study to evaluate the Company’s Thin Film Freezing technology to formulate dry powder universal influenza vaccines for pulmonary delivery TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative dru...
The following slide deck was published by TFF Pharmaceuticals, Inc. in conjunction with their 2019 Q4 earnings Read more ...
TFF Pharmaceuticals (NASDAQ: TFFP ): Q4 GAAP EPS of -$2.00. More news on: TFF Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
Conference call and live webcast scheduled for Thursday, March 26, 2020 at 4:30pm EDT TFF Pharmaceuticals, Inc. (NASDAQ:TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) te...
Conference call and live webcast was previously scheduled for 8:30 AM (EDT) TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology ...
Company to hold conference call and webcast at 8:30 AM EDT TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, today a...
News, Short Squeeze, Breakout and More Instantly...
TFF Pharmaceuticals Inc - Ordinary Shares Company Name:
TFFP Stock Symbol:
NASDAQ Market:
FORT WORTH, Texas, June 26, 2024 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP) (“the Company”), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology plat...
FDA Provided Constructive Feedback to Help Guide Next Steps in TFF TAC Clinical Development Company to Provide More Detailed Regulatory Update in 3Q 2024 FORT WORTH, Texas, June 24, 2024 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP) (“the Company”), a ...